PTGS2 and head and neck cancer: Additionally, the cyclooxygenase-2 (COX-2) signaling pathway is strongly linked to tumor angiogenesis in HNSCC, with COX-2 overexpression indicating a poorer prognosis for patients with head and neck cancer [8].